FDA
approval
· 2021-02-09
FDA Approved: TAVABOROLE — Original Application (Cipla USA Inc.)
Summary
The FDA approved Cipla USA Inc.'s original generic application for tavaborole, enabling a generic version of tavaborole topical solution for onychomycosis (nail…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TAVABOROLE (TAVABOROLE)